All data are based on the daily closing price as of March 18, 2026
c

Center Laboratories

4123.TWO
1.40 USD
0.01
+0.72%

Overview

Last close
1.40 usd
Market cap
1.04B usd
52 week high
1.59 usd
52 week low
0.93 usd
Target price
N/A usd

Valuation

P/E
3.8767
Forward P/E
2500
Price/Sales
21.8368
Price/Book Value
1.2585
Enterprise Value
1.16B usd
EV/Revenue
24.4446
EV/EBITDA
3.1024

Key financials

Revenue TTM
47.59M usd
Gross Profit TTM
19.50M usd
EBITDA TTM
-5.91M usd
Earnings per Share
0.36 usd
Dividend
N/A usd
Total assets
1.10B usd
Net debt
142.03M usd

About

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also offers central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells. In addition, the company engages in drug development, cell therapy, biotechnology, hydrogen energy, and dairy business. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.
  • Symbol
    4123.TWO
  • Exchange
    TWO
  • Isin
    TW0004123005
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Ms. Su-Chi Wang
  • Headquarter
    Taipei
  • Web site
    https://www.centerlab.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top